Quick Takeaways
- This page summarizes Diane Jorkasky's Form 4 filing for Altimmune, Inc. (ALT).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 29 Dec 2025, 16:10.
Diane Jorkasky - 29 Dec 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)
- Role
- Director
- Signature
- /s/ Gregory Weaver, as Attorney-in-Fact
- Issuer symbol
- ALT
- Transactions as of
- 29 Dec 2025
- Net transactions value
- +$2,003
- Form type
- 4
- Filing time
- 29 Dec 2025, 16:10:05 UTC
- Previous filing
- 29 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Diane Jorkasky filed Form 4 for Altimmune, Inc. (ALT) on 29 Dec 2025."
What Changed
- Previous filing in this sequence was filed on 29 Sep 2025.
- Current net transaction value: +$2,003.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jorkasky Diane | Director | 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG | /s/ Gregory Weaver, as Attorney-in-Fact | 29 Dec 2025 | 0001527204 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALT | Common Stock, par value $0.0001 | Purchase | $2,003 | +527 | $3.80 | 527 | 29 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.